Picture [iito] Männer Ballett 650x80px
Document › Details

Agena Bioscience, Inc.. (9/1/15). "Press Release: Agena Bioscience Opens Office in Shanghai, China". San Diego, CA.

Region Region Shanghai
  Country China
Organisations Organisation Agena Bioscience (Shanghai) Co., Ltd.
  Group Agena Bioscience (Group)
  Organisation 2 Qiagen (Group)
Products Product MassARRAY® system
  Product 2 genetics, molecular
Persons Person Dansky, Peter M. (Agena Bioscience 201407– CEO before Life Technologies + Applied Biosystems + Arcturus + Affymetrix)
  Person 2 Wang, Bob (Agena Bioscience 201509– VP + General Manager Greater China before Qiagen + Hologic)

Agena Bioscience today announced the establishment of a subsidiary in Shanghai, a commercial and financial hub from which many biotech and life science firms serve the growing number of genomic testing laboratories in mainland China.

“The Chinese market represents a significant portion of Agena Bioscience’s global sales with almost sixty MassARRAY® Systems installed to date. Direct presence within China will allow us to expand our reach and foster a high degree of engagement with our local customers in that region,” said Pete Dansky, CEO.

Bob Wang has joined Agena Bioscience as its Vice President and General Manager, Greater China. Bob most recently was Marketing Director for QIAGEN, responsible for leading the development of its molecular diagnostics and life science commercial strategies. Prior to this, Bob held senior positions encompassing Business Development, Marketing, Sales, and Regulatory Affairs at Hologic, Life Technologies, Applied Biosystems, and the Chinese Human Genome Center.

“We are delighted to have Bob leading our Greater China organization. His experience in both clinical diagnostics and life science research will help drive Agena Bioscience’s strategy and commercial execution in China,” said Dansky.

The MassARRAY System by Agena BioscienceTM provides a mid-plex technology for targeted profiling of 10’s to 100s of genetic markers. The system offers a practical solution for today’s clinical and translational research labs with improvements in cost, throughput, reimbursement, and ease of use over alternative methods. The MassARRAY System is used in 37 countries worldwide with an installed base of 350+ systems.

About Agena Bioscience

Agena Bioscience develops, manufactures, and supplies genetic analysis systems and reagents, including the MassARRAY System. The system is a highly sensitive, cost-effective, mass spectrometry-based platform for high-throughput genetic analysis, and is used globally in diverse fields such as cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research. The MassARRAY System is intended for research use only, and not intended for use in diagnostic procedures.

Record changed: 2019-06-09


Picture [iito] No Tracking 650x80px

More documents for Agena Bioscience (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

» top